rapcabtagene autoleucelcyclophosphamidefludarabineDiffuse cutaneous systemic sclerosis (dcSSc)Novartis Pharma AGdcSScCD19-targeted chimeric antigen receptor (CAR)-T cell therapy
…e and fludarabine, followed by a single intravenous infusion of rapcabtagene autoleucel, with the initial three dosed sequentially with a 28-day observ…